Aurobindo Pharma shares tumble nearly 7% in early trade; hit 52-week low after Q2 earnings
Aurobindo Pharma gains 3% in early trade
Bobcaps says ‘buy’ Aurobindo Pharma on Veritas Healthcare acquisition